Toyama, Japan

Junichi Yokotani


 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Junichi Yokotani: Innovator in Pharmaceutical Chemistry

Introduction

Junichi Yokotani is a noteworthy inventor based in Toyama, Japan. With a remarkable portfolio consisting of three patents, Yokotani has made significant contributions to the field of pharmaceutical chemistry, particularly in developing innovative compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, Yokotani has focused on the development of N-acyl anthranilic acid derivatives. One notable invention is centered around an N-acyl anthranilic acid derivative or its salt that exhibits collagen production inhibitory action. This compound holds promise as a remedy for conditions such as rheumatoid arthritis, osteoarthritis, and carcinoma due to its demonstrated inhibitory effect on MMP-13 production.

Additionally, he has developed an anthranilic acid derivative, represented by a complex general formula. This compound includes various possible substitutions that enhance its therapeutic potential, particularly associated with diseases involving collagen degradation.

Career Highlights

Yokotani’s innovative work is rooted in his career at Toyama Chemical Co., Ltd., where he has harnessed his expertise in chemistry to drive advancements in pharmaceutical research. His focus on creating effective compounds has established him as a prominent figure in his field.

Collaborations

Throughout his career, Yokotani has collaborated with notable coworkers, including Yoichi Taniguchi and Yukie Tada. These partnerships have played an essential role in advancing their shared goals in research and development, leading to groundbreaking inventions in pharmacology.

Conclusion

In conclusion, Junichi Yokotani epitomizes the spirit of innovation in pharmaceuticals. His work with N-acyl anthranilic acid derivatives reflects a profound commitment to addressing significant health challenges. With a promising career ahead, Yokotani continues to pave the way for future innovations in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…